Ryotaro Sakamori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ryotaro Sakamori has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Atsushi Takeno
Department of Surgery NHO Osaka National Hospital Osaka Japan
1 shared publication- Hiroko Hasegawa
NHO Osaka National Hospital
1 shared publication Kiyoshi Mori
Department of Central Laboratory and Surgical Pathology NHO Osaka National Hospital Osaka Japan
1 shared publicationMasayuki Mano
Department of Central Laboratory and Surgical Pathology NHO Osaka National Hospital Osaka Japan
1 shared publicationMizuki Koba
Department of Surgery NHO Osaka National Hospital Osaka Japan
1 shared publicationMotohiro Hirao
Department of Surgery NHO Osaka National Hospital Osaka Japan
1 shared publication
Latest Publications
- Open Access
- 25 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (6) , e72797
CIC–DUX4 Rearranged Gastric Sarcoma Confirmed by Next‐Generation Sequencing: A Case Report and Review of Literature
This case highlights that gastric CIC‐DUX4 rearranged sarcoma is highly aggressive and diagnostically challenging. Early comprehensive genomic profiling was essential for confirming this rare subtype. Despite transient responses to Ewing sarcoma regimens, rapid chemoresistance was observed, emphasizing the need for precise molecular diagnosis and novel therapeutic approaches.
- 25 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (6) , e72797
Open AccessCIC–DUX4 Rearranged Gastric Sarcoma Confirmed by Next‐Generation Sequencing: A Case Report and Review of Literature
This case highlights that gastric CIC‐DUX4 rearranged sarcoma is highly aggressive and diagnostically challenging. Early comprehensive genomic profiling was essential for confirming this rare subtype. Despite transient responses to Ewing sarcoma regimens, rapid chemoresistance was observed, emphasizing the need for precise molecular diagnosis and novel therapeutic approaches.